Document bB3EZkVKDqOEbzw9Nm2x3479g

Shanghai Health Study - Oversight Committee Call - June 26, 2003 Shell Notes SUBJECT: FUNDING Study Business Sponsors Call Dave O'Reilly, CEO ChevronTexaco and Chair API Executive Committee, will convene a call of the business sponsors from the 5 Benzene Health Research Consortium companies. The purpose of the call will be decide whether companies are willing to continue support of the study. Marty Bitter, ChevronTexaco Public Affairs Manager, will be making the call arrangements. Nancy Sullivan is the nominated person for Shell. Status of Project Budget on track for activities done - reported by Pat Beatty, chair Technical Committee. There is enough money in the committed dollars to fund the study through 2Q04. Marathon-Ashland has indicated willingness to contribute, but not at a fu1l2-share amount. API and Don Burnett, chair Oversight Committee, to follow up. SARS has impacted the schedule for accepting cases. GolNo Go Decision August 1 set as target date for making a go/no go decision on completing the study. Decision should be an outcome of the business sponsors calls. Potential impacts of No Go: o Focus of Annual Meeting in August o Accepting cases if there is a possibility of not completing the study. API and Pat Beatty will contact Dr. Brody, Ethics Committee. Financial Review by Shell Accountant Tarita Samuel, Shell accountant, will be at API on Wednesday, July 2, to review project accounting. This is being done at the request of the Budget Committee. SH ELL-MCCLU RG-067964